{"transactions":[{"id":947570,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T16:18:59.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7800,"derivative":{"exercise_price":6.76,"exercise_date":"2027-01-02","expiration_date":"2036-01-01","underlying":"Common  Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001453687-26-000035","document":"wk-form4_1767734336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368726000035/wk-form4_1767734336.xml","form_type":"4"}},{"id":947569,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T16:18:59.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2027."}],"balance_after":12974,"source":{"system":"sec-edgar","filing":"0001453687-26-000035","document":"wk-form4_1767734336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368726000035/wk-form4_1767734336.xml","form_type":"4"}},{"id":1311412,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-06T16:20:42.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7800,"derivative":{"exercise_price":16.93,"exercise_date":"2026-01-02","expiration_date":"2035-01-01","underlying":"Common  Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001453687-25-000024","document":"wk-form4_1736198433.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368725000024/wk-form4_1736198433.xml","form_type":"4"}},{"id":1311411,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T16:20:42.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":10374,"source":{"system":"sec-edgar","filing":"0001453687-25-000024","document":"wk-form4_1736198433.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368725000024/wk-form4_1736198433.xml","form_type":"4"}},{"id":1688571,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T17:04:47.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":228000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027."}],"balance_after":228000,"derivative":{"exercise_price":0.6552,"expiration_date":"2034-01-01","underlying":"Common  Stock","underlying_shares":228000},"source":{"system":"sec-edgar","filing":"0001453687-24-000018","document":"wk-form4_1704405850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368724000018/wk-form4_1704405850.xml","form_type":"4"}},{"id":1688570,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T17:04:47.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":178000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027."}],"balance_after":233248,"source":{"system":"sec-edgar","filing":"0001453687-24-000018","document":"wk-form4_1704405850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368724000018/wk-form4_1704405850.xml","form_type":"4"}},{"id":1741054,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T17:18:16.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"price":0.93,"value":69750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $69,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.13,"expiration_date":"2033-01-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001453687-23-000085","document":"wk-form4_1700086687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368723000085/wk-form4_1700086687.xml","form_type":"4"}},{"id":1741053,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T17:18:16.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":3.31,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001453687-23-000085","document":"wk-form4_1700086687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368723000085/wk-form4_1700086687.xml","form_type":"4"}},{"id":1741052,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T17:18:16.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":4.01,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001453687-23-000085","document":"wk-form4_1700086687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368723000085/wk-form4_1700086687.xml","form_type":"4"}},{"id":1741051,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T17:18:16.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":3,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001453687-23-000085","document":"wk-form4_1700086687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368723000085/wk-form4_1700086687.xml","form_type":"4"}},{"id":1741050,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T17:18:16.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option, which provided for vesting in full on June 14, 2020, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting in full on June 14, 2020, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":2.1,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001453687-23-000085","document":"wk-form4_1700086687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368723000085/wk-form4_1700086687.xml","form_type":"4"}},{"id":1741049,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T17:18:16.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":12.75,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001453687-23-000085","document":"wk-form4_1700086687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368723000085/wk-form4_1700086687.xml","form_type":"4"}},{"id":1741048,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T17:18:16.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12820,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on June 16, 2017, was canceled in the merger (the \"Merger\") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on June 16, 2017, was canceled in the merger (the \"Merger\") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc."}],"balance_after":0,"derivative":{"exercise_price":17.47,"expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":12820},"source":{"system":"sec-edgar","filing":"0001453687-23-000085","document":"wk-form4_1700086687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368723000085/wk-form4_1700086687.xml","form_type":"4"}},{"id":2068904,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T16:58:13.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying this award will vest in full on January 2, 2024."}],"balance_after":75000,"derivative":{"exercise_price":1.13,"expiration_date":"2033-01-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001453687-23-000014","document":"wf-form4_167286944573354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368723000014/wf-form4_167286944573354.xml","form_type":"4"}},{"id":2312246,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2022-04-01T20:05:31.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":49,"price":410.71,"value":20124.79,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."}],"balance_after":10928.2996,"derivative":{"underlying":"Common Stock","underlying_shares":49},"source":{"system":"sec-edgar","filing":"0001562180-22-003058","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218022003058/primarydocument.xml","form_type":"4"}},{"id":2444832,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T16:36:56.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying this award will vest in full on January 3, 2023."}],"balance_after":40000,"derivative":{"exercise_price":3.31,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001453687-22-000026","document":"wf-form4_164141859340066.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368722000026/wf-form4_164141859340066.xml","form_type":"4"}},{"id":2572655,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T14:51:02.000Z","date":"2021-09-09","kind":"gift","acquired":false,"shares":11517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Mr. Zenner contributed 3,837 vested shares equally to 3 separate trusts for which neither he nor any family member who lives with him is a trustee or beneficiary.  Mr. Zenner disclaims all pecuniary and voting interest in the shares contributed."}],"balance_after":55681.85,"source":{"system":"sec-edgar","filing":"0001562180-21-005919","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218021005919/primarydocument.xml","form_type":"4"}},{"id":2572654,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T14:51:02.000Z","date":"2021-05-04","kind":"gift","acquired":false,"shares":310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Zenner gifted 310 vested shares to a non-affiliated person."}],"balance_after":67198.85,"source":{"system":"sec-edgar","filing":"0001562180-21-005919","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218021005919/primarydocument.xml","form_type":"4"}},{"id":2725934,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-06T23:31:15.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":790,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of restricted stock units will vest in full on the first anniversary of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":67508.85,"source":{"system":"sec-edgar","filing":"0001562180-21-003314","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218021003314/primarydocument.xml","form_type":"4"}},{"id":2764745,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-01T18:35:13.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on March 30, 2022."}],"balance_after":40000,"derivative":{"exercise_price":4.01,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001453687-21-000049","document":"wf-form4_161731645484519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368721000049/wf-form4_161731645484519.xml","form_type":"4"}},{"id":2926902,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2021-01-04T17:48:03.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":132,"price":283.31,"value":37396.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."}],"balance_after":17026.8588,"derivative":{"underlying":"Common Stock","underlying_shares":132},"source":{"system":"sec-edgar","filing":"0001562180-21-000015","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218021000015/primarydocument.xml","form_type":"4"}},{"id":3001859,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:59:36.000Z","date":"2019-07-25","kind":"sale","acquired":false,"shares":47,"price":132.2151,"value":6214.1097,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a managed investment strategy involving the securities of multiple issuers. These managed accounts are held in a trust for which the reporting person is a trustee and/or beneficiary.  The reporting person was unaware of the transactions at the time they occurred and did not exercise any investment control over the purchases and sales. The reporting person has disgorged to the issuer all profits related to these purchases and sales."}],"balance_after":66139.878,"source":{"system":"sec-edgar","filing":"0001562180-20-006410","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020006410/primarydocument.xml","form_type":"4"}},{"id":3001858,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:59:36.000Z","date":"2019-07-18","kind":"sale","acquired":false,"shares":20,"price":121.8342,"value":2436.684,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a managed investment strategy involving the securities of multiple issuers. These managed accounts are held in a trust for which the reporting person is a trustee and/or beneficiary.  The reporting person was unaware of the transactions at the time they occurred and did not exercise any investment control over the purchases and sales. The reporting person has disgorged to the issuer all profits related to these purchases and sales."}],"balance_after":66186.878,"source":{"system":"sec-edgar","filing":"0001562180-20-006410","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020006410/primarydocument.xml","form_type":"4"}},{"id":3001857,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:59:36.000Z","date":"2019-03-21","kind":"sale","acquired":false,"shares":33,"price":106.4856,"value":3514.0248,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a managed investment strategy involving the securities of multiple issuers. These managed accounts are held in a trust for which the reporting person is a trustee and/or beneficiary.  The reporting person was unaware of the transactions at the time they occurred and did not exercise any investment control over the purchases and sales. The reporting person has disgorged to the issuer all profits related to these purchases and sales."}],"balance_after":66206.878,"source":{"system":"sec-edgar","filing":"0001562180-20-006410","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020006410/primarydocument.xml","form_type":"4"}},{"id":3001856,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:59:36.000Z","date":"2019-03-19","kind":"sale","acquired":false,"shares":11,"price":106.0163,"value":1166.1793,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a managed investment strategy involving the securities of multiple issuers. These managed accounts are held in a trust for which the reporting person is a trustee and/or beneficiary.  The reporting person was unaware of the transactions at the time they occurred and did not exercise any investment control over the purchases and sales. The reporting person has disgorged to the issuer all profits related to these purchases and sales."}],"balance_after":66239.878,"source":{"system":"sec-edgar","filing":"0001562180-20-006410","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020006410/primarydocument.xml","form_type":"4"}},{"id":3001855,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:59:36.000Z","date":"2019-02-28","kind":"purchase","acquired":true,"shares":54,"price":105.1371,"value":5677.4034,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a managed investment strategy involving the securities of multiple issuers. These managed accounts are held in a trust for which the reporting person is a trustee and/or beneficiary.  The reporting person was unaware of the transactions at the time they occurred and did not exercise any investment control over the purchases and sales. The reporting person has disgorged to the issuer all profits related to these purchases and sales."}],"balance_after":66250.878,"source":{"system":"sec-edgar","filing":"0001562180-20-006410","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020006410/primarydocument.xml","form_type":"4"}},{"id":3001854,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:59:36.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":57,"price":110.5529,"value":6301.5153,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a managed investment strategy involving the securities of multiple issuers. These managed accounts are held in a trust for which the reporting person is a trustee and/or beneficiary.  The reporting person was unaware of the transactions at the time they occurred and did not exercise any investment control over the purchases and sales. The reporting person has disgorged to the issuer all profits related to these purchases and sales."}],"balance_after":66196.878,"source":{"system":"sec-edgar","filing":"0001562180-20-006410","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020006410/primarydocument.xml","form_type":"4"}},{"id":3001853,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:59:36.000Z","date":"2017-11-10","kind":"sale","acquired":false,"shares":335,"price":101.5426,"value":34016.771,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a managed investment strategy involving the securities of multiple issuers. These managed accounts are held in a trust for which the reporting person is a trustee and/or beneficiary.  The reporting person was unaware of the transactions at the time they occurred and did not exercise any investment control over the purchases and sales. The reporting person has disgorged to the issuer all profits related to these purchases and sales."}],"balance_after":66139.878,"source":{"system":"sec-edgar","filing":"0001562180-20-006410","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020006410/primarydocument.xml","form_type":"4"}},{"id":3001852,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:59:36.000Z","date":"2017-10-17","kind":"purchase","acquired":true,"shares":335,"price":93.9367,"value":31468.7945,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a managed investment strategy involving the securities of multiple issuers. These managed accounts are held in a trust for which the reporting person is a trustee and/or beneficiary.  The reporting person was unaware of the transactions at the time they occurred and did not exercise any investment control over the purchases and sales. The reporting person has disgorged to the issuer all profits related to these purchases and sales."}],"balance_after":66474.878,"source":{"system":"sec-edgar","filing":"0001562180-20-006410","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020006410/primarydocument.xml","form_type":"4"}},{"id":3017615,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2020-10-02T19:43:40.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":136,"price":274.9,"value":37386.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."}],"balance_after":16894.8588,"derivative":{"underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001562180-20-006202","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020006202/primarydocument.xml","form_type":"4"}},{"id":3094178,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2020-07-02T17:23:21.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":165,"price":227.17,"value":37483.05,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."}],"balance_after":16758.8588,"derivative":{"underlying":"Common Stock","underlying_shares":165},"source":{"system":"sec-edgar","filing":"0001562180-20-004777","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020004777/primarydocument.xml","form_type":"4"}},{"id":3102156,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:48:15.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 19, 2021 or the day immediately prior to the company's 2021 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":3,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001453687-20-000080","document":"wf-form4_159294527766997.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368720000080/wf-form4_159294527766997.xml","form_type":"4"}},{"id":3158872,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-07T22:01:10.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":1283,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of restricted stock units will vest in full on the first anniversary of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":66139.878,"source":{"system":"sec-edgar","filing":"0001562180-20-003459","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020003459/primarydocument.xml","form_type":"4"}},{"id":3188087,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2020-04-02T17:24:01.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":246,"price":152.25,"value":37453.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."}],"balance_after":16593.8588,"derivative":{"underlying":"Common Stock","underlying_shares":246},"source":{"system":"sec-edgar","filing":"0001562180-20-002825","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218020002825/primarydocument.xml","form_type":"4"}},{"id":3310042,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:56:38.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.23,"expiration_date":"2027-05-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-004721","document":"tm203607d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004721/tm203607d7_4.xml","form_type":"4"}},{"id":3310041,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:56:38.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.68,"expiration_date":"2026-05-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-004721","document":"tm203607d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004721/tm203607d7_4.xml","form_type":"4"}},{"id":3310040,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:56:38.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.8,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-004721","document":"tm203607d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004721/tm203607d7_4.xml","form_type":"4"}},{"id":3310039,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:56:38.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.42,"expiration_date":"2024-05-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-004721","document":"tm203607d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004721/tm203607d7_4.xml","form_type":"4"}},{"id":3310038,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:56:38.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.78,"expiration_date":"2023-05-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-004721","document":"tm203607d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004721/tm203607d7_4.xml","form_type":"4"}},{"id":3310037,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:56:38.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":5.82,"expiration_date":"2022-05-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-004721","document":"tm203607d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004721/tm203607d7_4.xml","form_type":"4"}},{"id":3310036,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:56:38.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":6.71,"expiration_date":"2021-06-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-004721","document":"tm203607d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004721/tm203607d7_4.xml","form_type":"4"}},{"id":3310035,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:56:38.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":6.21,"expiration_date":"2029-05-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-20-004721","document":"tm203607d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004721/tm203607d7_4.xml","form_type":"4"}},{"id":3310034,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T15:56:38.000Z","date":"2020-01-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.48,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-004721","document":"tm203607d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004721/tm203607d7_4.xml","form_type":"4"}},{"id":3310033,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-16T15:56:38.000Z","date":"2020-01-16","kind":"other","acquired":false,"shares":122216,"price":20,"value":2444320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 6, 2019, ArQule, Inc. (the \"Company\") entered into an Agreement and Plan of Merger (as amended, supplemented or otherwise modified from time to time, the \"Merger Agreement\") with Merck Sharpe & Dohme Corp. (\"MSD\") and Argon Merger Sub, Inc., a wholly-owned subsidiary of MSD (\"Merger Sub\"), pursuant to which MSD acquired the Company by a tender offer for all shares of Company common stock (the \"Offer\") and a subsequent merger (the \"Merger\"), each of which became effective on January 16, 2020. Pursuant to the Merger Agreement, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to $20.00 per share (the \"Offer Price\") and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), were cancelled and converted automatically into the right to receive the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-004721","document":"tm203607d7_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000110465920004721/tm203607d7_4.xml","form_type":"4"}},{"id":3406572,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-09-25T10:40:57.000Z","date":"2019-09-24","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.14,"expiration_date":"2020-05-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001019695-19-000031","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969519000031/primary_doc.xml","form_type":"4"}},{"id":3406571,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-25T10:40:57.000Z","date":"2019-09-24","kind":"exercise","acquired":true,"shares":25000,"price":6.14,"value":153500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exercise of 25,000 shares for cash that were subject to an option.  All exercised shares were retained by Mr. Zenner and no shares were sold."}],"balance_after":122216,"source":{"system":"sec-edgar","filing":"0001019695-19-000031","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969519000031/primary_doc.xml","form_type":"4"}},{"id":3433373,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-20T16:29:58.000Z","date":"2019-08-20","kind":"grant","acquired":true,"shares":55248,"price":1.81,"value":99998.88,"ownership":{"direct":true},"balance_after":55248,"source":{"system":"sec-edgar","filing":"0001453687-19-000120","document":"wf-form4_156633298315611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368719000120/wf-form4_156633298315611.xml","form_type":"4"}},{"id":3486459,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-18T16:22:40.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 14, 2020 or the day immediately prior to the company's 2020 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":2.1,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001453687-19-000075","document":"wf-form4_156088934496556.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000145368719000075/wf-form4_156088934496556.xml","form_type":"4"}},{"id":3526514,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options","published_at":"2019-05-15T12:50:20.000Z","date":"2019-05-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 1 year from date of grant."}],"balance_after":50000,"derivative":{"exercise_price":6.21,"expiration_date":"2029-05-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001019695-19-000024","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969519000024/primary_doc.xml","form_type":"4"}},{"id":3534358,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-09T19:11:16.000Z","date":"2019-05-07","kind":"grant","acquired":true,"shares":494,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of restricted stock units will vest in full on the first anniversary of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":58598.5691,"source":{"system":"sec-edgar","filing":"0001562180-19-002732","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218019002732/primarydocument.xml","form_type":"4"}},{"id":3534357,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-09T19:11:16.000Z","date":"2019-05-07","kind":"grant","acquired":true,"shares":1565,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of restricted stock units will vest in full on the first anniversary of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."}],"balance_after":58104.5691,"source":{"system":"sec-edgar","filing":"0001562180-19-002732","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218019002732/primarydocument.xml","form_type":"4"}},{"id":3560762,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-04-08T16:58:54.000Z","date":"2019-04-05","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.87,"expiration_date":"2019-05-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001019695-19-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969519000011/primary_doc.xml","form_type":"4"}},{"id":3560761,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-08T16:58:54.000Z","date":"2019-04-05","kind":"exercise","acquired":true,"shares":15000,"price":3.87,"value":58050.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exercise of 15,000 shares that were subject to an option. All exercised shares were retained by Mr. Patrick J. Zenner and no shares were sold."}],"balance_after":97216,"source":{"system":"sec-edgar","filing":"0001019695-19-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969519000011/primary_doc.xml","form_type":"4"}},{"id":3889107,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-19T19:01:40.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 15, 2019 or the day immediately prior to the company's 2019 annual meeting of shareholders."}],"balance_after":10000,"derivative":{"exercise_price":12.75,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001638599-18-000670","document":"doc4_5488.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000163859918000670/doc4_5488.xml","form_type":"4"}},{"id":3929858,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T21:20:30.000Z","date":"2018-05-15","kind":"purchase","acquired":true,"shares":275,"price":88.8884,"value":24444.31,"ownership":{"direct":true},"balance_after":56539.5691,"source":{"system":"sec-edgar","filing":"0001562180-18-002553","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018002553/primarydocument.xml","form_type":"4"}},{"id":3933476,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-15T11:37:44.000Z","date":"2018-05-14","kind":"purchase","acquired":true,"shares":8446,"price":2.9584,"value":24986.6464,"ownership":{"direct":true},"balance_after":82216,"source":{"system":"sec-edgar","filing":"0001019695-18-000018","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969518000018/primary_doc.xml","form_type":"4"}},{"id":3936309,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T15:58:05.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Due to a clerical error, this grant was omitted on the orginal submission of the form on behalf of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of restricted stock will vest 1/4th on a quarterly basis starting August 1, 2018, will accrue dividends and will be transferred upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":56264.5691,"source":{"system":"sec-edgar","filing":"0001562180-18-002459","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018002459/primarydocument.xml","form_type":"4/A","original_submission_date":"2018-05-03"}},{"id":3939558,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options","published_at":"2018-05-10T12:50:16.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 1 year from the date of grant May 8, 2018."}],"balance_after":25000,"derivative":{"exercise_price":2.48,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001019695-18-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969518000007/primary_doc.xml","form_type":"4"}},{"id":3949028,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-03T21:44:14.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":1824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of restricted stock units will vest in full on the first anniversay of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":55680.5691,"source":{"system":"sec-edgar","filing":"0001562180-18-002193","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018002193/primarydocument.xml","form_type":"4"}},{"id":4276252,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-20T16:38:20.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":12820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant."}],"balance_after":12820,"derivative":{"exercise_price":17.47,"expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":12820},"source":{"system":"sec-edgar","filing":"0001638599-17-000637","document":"doc4_4805.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139036/000163859917000637/doc4_4805.xml","form_type":"4"}},{"id":4306920,"issuer":{"id":11927,"kind":"organization","name":"ARQULE INC","symbol":"ARQL"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options","published_at":"2017-05-24T11:16:42.000Z","date":"2017-05-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one year from the date of grant May 23, 2017."}],"balance_after":25000,"derivative":{"exercise_price":1.23,"expiration_date":"2027-05-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001019695-17-000020","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019695/000101969517000020/primary_doc.xml","form_type":"4"}},{"id":4336645,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-03T18:58:51.000Z","date":"2017-05-02","kind":"grant","acquired":true,"shares":528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This award vests in 4 equal quarterly installments beginning on 08/01/2017."}],"balance_after":53856.5691,"source":{"system":"sec-edgar","filing":"0001562180-17-001693","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017001693/primarydocument.xml","form_type":"4"}},{"id":4336644,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-03T18:58:51.000Z","date":"2017-05-02","kind":"grant","acquired":true,"shares":1697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of restricted stock units will vest in full after 12 months and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":53328.5691,"source":{"system":"sec-edgar","filing":"0001562180-17-001693","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017001693/primarydocument.xml","form_type":"4"}},{"id":4522950,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-14T16:48:30.000Z","date":"2016-12-13","kind":"gift","acquired":false,"shares":330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"165 shares each were gifted to two separate private trusts"}],"balance_after":51501.1253,"source":{"system":"sec-edgar","filing":"0001562180-16-003768","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218016003768/primarydocument.xml","form_type":"4"}},{"id":4527937,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":70084,"kind":"person","name":"ZENNER PATRICK J","position":1,"cik":"0001139036","reported_name":"ZENNER PATRICK J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-09T15:34:25.000Z","date":"2016-12-08","kind":"purchase","acquired":true,"shares":332,"price":84.528,"value":28063.296,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $84.52 to $84.54, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":51831.1253,"source":{"system":"sec-edgar","filing":"0001562180-16-003705","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218016003705/primarydocument.xml","form_type":"4"}}]}